Pages

Friday, August 29, 2014

Business Object Developer in San Francisco 8+ eXp


 

Business Object Developer

Location: San Francisco Location,

Length: 6 months,

 

 Senior business objects developer with an understanding of clinical pharmaceutical systems is needed to perform coding and development of customized trial system reporting.  Candidate should have 8 years experience and a recent project within a clinical life science environment.

Perform design, development, validation, implementation, and provide ongoing support for reporting/business intelligence tools in Business Objects and SQAL used in Clinical Research and Development studies. The responsibilities include:

  • Design and implement Business Objects reports and dashboards with a variety of visualization techniques to assist users in identifying critical data quickly and accurately
  • Review, analyze, and evaluate business systems and user needs
  • Ensure assigned tasks are completed within the given timeframe
  • Assist in the documentation and testing of developed reports and dashboards
  • Work with customers to understand business needs and deliver high quality solutions

 

 

--

  

 ------------------------

Thanks & Regards,

Tarun Vohra

Sr. Team Lead

Sage Group Consulting, Inc.

3400 Highway 35, Suite # 9, Hazlet, NJ 07730

Direct Phone: 732-479-1329

Office: 732-767-0010 EXT:210

Fax: 732-479-1329

Email    : tvohra@sagetl.com

Website : www.sageci.com

Yahoo IM : tarun.vohra

Gtalk IM : tarun.vohra84

--
You received this message because you are subscribed to the Google Groups "Jobs for USA consultants (Citizen G.C and H1B)" group.
To unsubscribe from this group and stop receiving emails from it, send an email to jobs-for-usa-consultants-citizen-gc-and-h1b+unsubscribe@googlegroups.com.
To post to this group, send email to jobs-for-usa-consultants-citizen-gc-and-h1b@googlegroups.com.
Visit this group at http://groups.google.com/group/jobs-for-usa-consultants-citizen-gc-and-h1b.
For more options, visit https://groups.google.com/d/optout.

0 comments:

Post a Comment